Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.
Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, Moghaddam B, Ahuja V, Ali SA, Allez M, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Kotze PG, Koutroubakis IE, Lakatos PL, Lindsay JO, Magro F, Mantzaris GJ, Ng SC, O'Morain C, Panés J, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Siegmund B, Steinwurz F, Tysk C, Vavricka S, Verstraete SG, Brezin AP, Haemel AK, Dignass A, Sands BE, Danese S, Peyrin-Biroulet L. Guillo L, et al. Among authors: sands be. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):254-261. doi: 10.1016/S2468-1253(21)00297-1. Epub 2022 Jan 17. Lancet Gastroenterol Hepatol. 2022. PMID: 35051383
Novel therapies for inflammatory bowel disease.
Sands BE. Sands BE. Gastroenterol Clin North Am. 1999 Jun;28(2):323-51. doi: 10.1016/s0889-8553(05)70059-5. Gastroenterol Clin North Am. 1999. PMID: 10372271 Review.
Therapy of inflammatory bowel disease.
Sands BE. Sands BE. Gastroenterology. 2000 Feb;118(2 Suppl 1):S68-82. doi: 10.1016/s0016-5085(00)70007-2. Gastroenterology. 2000. PMID: 10868899 Review.
Design issues and outcomes in IBD clinical trials.
Sands BE, Abreu MT, Ferry GD, Griffiths AM, Hanauer SB, Isaacs KL, Lewis JD, Sandborn WJ, Steinhart AH. Sands BE, et al. Inflamm Bowel Dis. 2005 Nov;11 Suppl 1:S22-8. doi: 10.1097/01.mib.0000184849.38816.39. Inflamm Bowel Dis. 2005. PMID: 16254479 Review.
State of the art: IBD therapy and clinical trials in IBD.
Isaacs KL, Lewis JD, Sandborn WJ, Sands BE, Targan SR. Isaacs KL, et al. Among authors: sands be. Inflamm Bowel Dis. 2005 Nov;11 Suppl 1:S3-12. doi: 10.1097/01.mib.0000184852.84558.b2. Inflamm Bowel Dis. 2005. PMID: 16254481 Review.
360 results